Leaflet: information for the user
Naramig 2.5 mg film-coated tablets
Naratriptan
Read this leaflet carefully before you start taking this medicine, because it contains important information for you.
The Naramig tablets contain naratriptan (hydrochloride), which belongs to a group of medicines called triptans (also known as 5-HT1 receptor agonists).
Naramig tablets are used for the treatment of headache that occurs in migraine.
The symptoms of migraine may be due to temporary dilation of blood vessels inlthe head. It is believed that Naramig reduces the dilation of these blood vessels, which helps to eliminate the headache andalleviate other symptoms of migraine, such as nausea and vomiting and sensitivity to light andal sound.
Do not take Naramig:
If you are in any of these situations:
→Inform your doctor and do not take Naramig.
Warnings and precautions
Consult your doctor or pharmacist before starting to take Naramig.
If you have any risk factors:
In very rare cases, people have experienced severe cardiac alterations after taking Naramig, although they had no history of heart disease.
If you are in any of the above situations, you may be at a higher risk of heart disease. Therefore:
→Inform your doctor so that your cardiac function can be reviewedbefore starting treatment with Naramig.
If you are allergic to sulfonamide antibiotics
If so,you may also be allergic to Naramig. If you are allergic to an antibiotic but are not sure if it is a sulfonamide:
→Inform your doctor or pharmacist before starting to take Naramig.
If you take Naramig frequently
Taking Naramig too frequently may worsen your headaches.
→Inform your doctorif you are in this situation.Your doctor may recommend that you stop taking Naramig.
If you feel pain or tension in your chest after taking Naramig
These effects can be intense but are generally transient. If they do not disappear quickly or become more severe:
→Go to your doctor immediately. Section 4 of this leaflet has more information about this side effect.
If you are taking antidepressants called SSRIs (
Selective serotonin reuptake inhibitors) orSNRIs (
serotonin and noradrenaline reuptake inhibitors), used to treat depression
→Inform your doctor or pharmacist before starting to take Naramig.
Use of Naramig with other medications
Inform your doctor or pharmacist if you are taking,have taken recently or may need to take any other medication, including herbal remedies or over-the-counter medications.
Some medications should not be taken with Naramig and others may cause side effects if taken together with Naramig.Inform your doctor if you are taking:
Driving and operating machinery
Naramig contains lactose
This medication contains lactose. If your doctor has told you that you have a certain sugar intolerance:
→Consult with them beforetaking this medication.
This medication contains less than 23 mg of sodium (1mmol) per tablet; it is essentially “sodium-free”.
Take Naramig only after your migraine has started
Do not take Naramig to prevent an attack
Follow exactly the administration instructions of this medication indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
What is the dose you should take
Naramig is not recommended for children under 18 years or adults over 65 years.
When to take your dose
When symptoms start to appear again
When the first dose does not provide relief
If Naramig does not provide any relief:
?Ask your doctor or pharmacist.
When taking more Naramig than you should
If you take more Naramig than you should, you may become ill. If you have taken more than 2 tablets in 24 hours:
?Inform your doctor or call the Toxicological Information Service, phone 91.562.04.20, indicating the medication and the amount taken.
If you have any other doubtabout the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine may cause side effects, although not everyone will experience them.
Allergic reaction: seek medical attention immediately(may affect up to1 in 1,000 people)
If you experience any of these symptoms shortly after taking Naramig:
→Do not take any more tablets and contact a doctor immediately.
Common side effects(may affect up to1 in 10 people)
If you experience any of these side effects:
→Inform your doctor or pharmacist.
Less common side effects(may affect up to1 in 100 people)
If these side effects continue or worsen, especially chest pain:
→Seek urgent medical attention.In a small number of people, these symptoms may be caused by a heart attack.
Other less common side effects include:
If you experience these side effects:
→Inform your doctor or pharmacist.
Rare side effects(may affect up to1 in 1,000 people)
If you experience these side effects:
→Inform your doctor or pharmacist.
Very rare side effects(may affect up to1 in 10,000 people)
If you experience these side effects:
→Inform your doctor or pharmacist.
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect not listed in this leaflet. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use,www.notificaRAM.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date shown on the packaging (EXP). The expiration date is the last day of the month indicated.
Do not store above 86°F (30°C).
Dispose of unused medications and packaging through the SIGRE collection point at your pharmacy. If in doubt, ask your pharmacist how to dispose of unused medications and packaging. By doing so, you will help protect the environment.
Composition of Naramig
The active principleis naratriptan (2.5 mg), as hydrochloride.
The other componentsof the tablet core are: microcrystalline cellulose, anhydrous lactose, sodium croscarmellose, and magnesium stearate. The other components of the tablet coating are: hypromellose, titanium dioxide (E171), triacetin, yellow iron oxide (E172), and indigotin (indigo carmine (E132)).
Appearance of the product and contents of the package
Naramig tablets are green, film-coated, D-shaped, and engraved with GX CE5 on one side. They are available in blister packs resistant to children that contain 2, 4, 6, or 12 tablets.
Only some package sizes may be marketed.
Marketing authorization holder and responsible manufacturer
Marketing authorization holderGlaxo, S.A.
P.T.M. C/ Severo Ochoa, 2
28760 Tres Cantos (Madrid)
Tel: +34 900 202 700
Responsible manufacturerDelpharm Poznan Spólka Akcyjna
ul. Grunwaldzka 189
60-322 Poznan
Poland
This medicine is authorized in the member states of the European Economic Area with the following names:
BelgiumNaramig
FinlandNaramig
FranceNaramig
GermanyNaramig
GreeceNaramig
LuxembourgNaramig
NetherlandsNaramig
PortugalNaramig
SpainNaramig
SwedenNaramig
Last review date of this leaflet:June 2020.
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
The average price of Naramig 2,5 mg comprimidos recubiertos con pelicula in July, 2025 is around 19.14 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.